IntelGenx Technologies Corp. announced the resignation of Frank Stegert and Srinivas Rao from the Board of Directors of the Company (the ?Board?) effective December 2, 2023. Mr. Stegert and Dr. Rao were the Board designees for atai Life Sciences AG (?atai?) pursuant to the purchaser rights agreement by and between the Company and atai (the ?Rights Agreement?).

On December 2, 2023, the Board appointed Sahil Kirpekar, M.D. and Ryan Barrett as the new atai Board designees pursuant to the Rights Agreement, to serve until the 2024 annual meeting of the Company?s stockholders, or until their respective successors are duly elected and qualified. Dr. Kirpekar has served as atai?s Chief Business Officer since 2022 and Mr. Barrett has served as atai?s Senior Vice President and General Counsel since August 2020.